<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="149772">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02041988</url>
  </required_header>
  <id_info>
    <org_study_id>1846/08.04.10</org_study_id>
    <nct_id>NCT02041988</nct_id>
  </id_info>
  <brief_title>Preemptive Analgesia With Morphine Sulphate in Major Urological Surgery</brief_title>
  <official_title>Influence of Premedication With Oral Morphine Sulphate on Analgesic Consumption in Patient Undergoing Major Urological Surgery. Comparison Between Two Different Doses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <authority>Italy: The Italian Medicines Agency</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study safety and efficacy of oral morphine sulphate is evaluated in order to reduce
      opioids administration during major urological surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The administration of oral morphine sulfate could be useful to reduce the use of opioids in
      major urological surgery. This study aims to assess the safety and efficacy of two different
      oral morphine sulphate doses 0,2 mg/kg vs 0,4mg/kg in major urological surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control</study_design>
  <primary_outcome>
    <measure>morphine sulphate consumption</measure>
    <time_frame>six months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>vital signs</measure>
    <time_frame>six months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>VAS score</measure>
    <time_frame>six months</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>side effects</measure>
    <time_frame>six months</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>0,2 mg/kg oral morphine</arm_group_label>
    <description>Patients have been assigned to two groups of 20 individuals, they have been premedicated with oral morphine sulfate, 0,2 mg/kg group A, 0,4mg/kg group B.During surgery analgesic administration will be monitored</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0,4 mg/ kg oral morphine</arm_group_label>
    <description>morphine and analgesic consumption throughout surgery will be monitored</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients selected for major urological surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        American Society of Anaesthesiologists physical status classification  I/ II, age between
        18 - 75, BMI 18 -30

        Exclusion Criteria:

        American Society of Anaesthesiologists physical status classification  III/ IV, renal and
        hepatic insufficiency, postoperative nausea and vomiting after oral opioids
        administrations, neurological and psychiatric disorders.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesco MD Cannata, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Policlinico Umberto I</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesco FC Cannata, MD</last_name>
    <phone>+390649970283</phone>
    <email>francesco.cannata@uniroma1.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Policlinico Umberto I</name>
      <address>
        <city>Rome</city>
        <zip>00141</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco FC Cannata, MD</last_name>
      <phone>+390649970283</phone>
      <email>francesco.cannata@uniroma1.it</email>
    </contact>
    <investigator>
      <last_name>Francesco FC Cannata, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Francesco Cannata</name>
      <address>
        <city>Rome</city>
        <zip>00141</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco FC Cannata, MD</last_name>
      <phone>+390649970283</phone>
      <email>francesco.cannata@uniroma1.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 17, 2014</lastchanged_date>
  <firstreceived_date>July 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Francesco Cannata</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>premedication</keyword>
  <keyword>oral morphine</keyword>
  <keyword>preemptive analgesia</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
